Changes in estimated glucose disposal rate and future stroke risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3.
Changes in how the body processes glucose can predict future stroke risk, helping identify vulnerable patients earlier.
Researchers found that tracking changes in how the body processes glucose can predict future stroke risk in people with early cardiovascular-kidney-metabolic syndrome. This biomarker could help identify high-risk patients before stroke occurs.
What the study was
- Study design
- Cohort study
- Population
- Individuals with CKM syndrome stages 0-3
- Category
- Early Detection
- Maturity
- Validated
- Journal
- Scientific Reports
Why it surfaced
Cardiometabolic risk prediction for CKM syndrome patients. Clinically relevant but incremental.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.